Monopar Therapeutics

MNPR·NASDAQ·$62.62Share Price as of 11/2·$419MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/14/26 10-K/AFY 202504/01/26 10-KFY 202503/27/26 10-QQ3 ended 09/30/2511/13/25

Disclosures

8-KCurrent report08/12/26 8-KCurrent report07/22/26 8-KCurrent report06/30/26 8-KCurrent report06/26/26 8-KCurrent report06/23/26

Prospectuses and Registrations

S-8Registration of securities for employees07/22/26 S-8 POSPost-effective amendment (S-8)07/22/26 S-8 POSPost-effective amendment (S-8)07/22/26 S-8 POSPost-effective amendment (S-8)07/22/26 S-8 POSPost-effective amendment (S-8)07/22/26

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 DEFA14AAdditional proxy materials05/23/25 DEF 14ADefinitive proxy04/30/25 DEF 14ADefinitive proxy07/22/24

Ownership

Form 4Insider transaction10/20/26 Form 4Insider transaction10/05/26 Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26

Other

ARSAnnual report to shareholders04/30/26 EFFECTRequest for effectiveness09/09/25 CORRESPCorrespondence with the SEC09/05/25 UPLOADLetter from the SEC09/04/25 UPLOADLetter from the SEC07/25/25